Endosure

Endosure, Inc. was created based upon a new approach to support physicians in the diagnosis of endometriosis. The EndoSure Test* is uniquely poised to change the diagnostic paradigm for endometriosis and facilitate the pathway to early diagnosis, which in turn can enhance timely treatment options. Our first of its kind non-invasive, 30-minute endometriosis clinical decision support tool offers the promise to improve the lives and livelihoods of the hundreds of millions of women that suffer from this disease yearly. Supporting the Company’s compelling technology is a world class senior team with transformational skills that will enhance commercialization.

The Only Non-Invasive, 30 Minute Clinical Decision Support Tool to Facilitate Your Diagnosis of Endometriosis.
Women worldwide suffer for an average of 8.6 years before being diagnosed with endometriosis.⁴ Leading the charge to change this, the EndoSure Test* takes 30 minutes and provides physicians with simple, objective data to support a rapid diagnosis of endometriosis.
Endometriosis is a debilitating disease that effects over 10% of women globally. As a clinical decision support tool the EndoSure Test* is the only noninvasive, 30-minute, objective test to help physicians quickly and accurately diagnose endometriosis regardless of disease stage. The test is a game changer in how physicians diagnose endometriosis, and can be used during the initial encounter for patients presenting with pelvic or menstrual pain and for those requiring post-treatment monitoring.